Table 1.
Variables | Training phase | Validation phase | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Plasma samples | Tissues samples | Plasma samples | ||||||||
CRC | adenoma | HC | CRC | adenoma | HC | Pre/post | CRC | adenoma | HC | |
Number | 15 | 15 | 15 | 20 | 20 | 20 | 15 | 80 | 50 | 30 |
Age (mean±SD) | 62.4 ± 10.9 | 61.2 ± 12.1 | 61.4 ± 11.2 | 61.5 ± 10.6 | 60.2 ± 11.7 | 58.4 ± 10.8 | 62.6 ± 9.3 | 63.7 ± 9.2 | 62.2 ± 9.6 | 59.4 ± 10.3 |
Gender | ||||||||||
Male | 10 | 12 | 10 | 14 | 15 | 13 | 11 | 53 | 34 | 19 |
Female | 5 | 3 | 5 | 6 | 5 | 7 | 4 | 27 | 16 | 11 |
Drinking status | ||||||||||
never | 4 | 2 | 3 | 6 | 4 | 6 | 3 | 29 | 19 | 12 |
ever | 11 | 13 | 12 | 14 | 16 | 14 | 12 | 51 | 31 | 18 |
Tumor stage | ||||||||||
I | 5 | 5 | 4 | 24 | ||||||
II | 6 | 8 | 6 | 31 | ||||||
III | 2 | 4 | 3 | 16 | ||||||
IV | 2 | 3 | 2 | 9 |